tradingkey.logo

Alignment Healthcare Inc

ALHC

16.770USD

-0.949-5.36%
收盘 05/01, 16:00美东报价延迟15分钟
3.22B总市值
亏损市盈率 TTM

Alignment Healthcare Inc

16.770

-0.949-5.36%
关于 Alignment Healthcare Inc 公司
Alignment Healthcare, Inc. 提供以消费者为中心的医疗保健平台,旨在为老年人提供医疗保健服务。该公司的业务包括加利福尼亚州、北卡罗来纳州、内华达州、亚利桑那州、佛罗里达州和德克萨斯州的医疗保险优势计划。其消费者品牌 Alignment Health 提供 50 多个医疗保险优势计划,服务于六个州的 53 个县。该公司与全国知名和本地供应商合作,提供协调护理,由其定制护理模式、24/7 礼宾护理团队和专用技术 Alignment 的虚拟应用程序 (AVA) 提供支持。AVA 专为老年人护理而设计,提供医疗保健生态系统的端到端协调。AVA 的工具和服务套件建立在统一的数据架构内。医疗保险优势计划直接面向消费者,为医院保险福利、门诊服务和处方药保险提供单点护理服务。
公司简介
公司代码ALHC
公司名称Alignment Healthcare Inc
上市日期Mar 26, 2021
成立日期2014
CEOMr. John E. Kao
员工数量1679
证券类型Ordinary Share
年结日Mar 26
公司地址1100 W. Town And Country Road
城市ORANGE
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编92868
电话18443102247
网址https://www.alignmenthealth.com/
公司代码ALHC
上市日期Mar 26, 2021
成立日期2014
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. John E. Kao
Mr. John E. Kao
Chief Executive Officer, Director
Chief Executive Officer, Director
5.35M
+68.63%
Mr. Joseph S. Konowiecki
Mr. Joseph S. Konowiecki
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
862.50K
+1.44%
Mr. Robert L. Scavo
Mr. Robert L. Scavo
Chief Information Officer
Chief Information Officer
702.95K
+60.92%
Mr. Christopher J. Joyce, J.D.
Mr. Christopher J. Joyce, J.D.
Chief Legal and Administrative Officer
Chief Legal and Administrative Officer
415.02K
-5.68%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
327.44K
+3.89%
Dr. Jacqueline B. Kosecoff
Dr. Jacqueline B. Kosecoff
Independent Director
Independent Director
250.87K
+5.14%
Mr. Sebastian Burzacchi
Mr. Sebastian Burzacchi
Chief Operating Officer - Management Services Organization
Chief Operating Officer - Management Services Organization
250.38K
+15.17%
Ms. Margaret M. (Meg) Mccarthy
Ms. Margaret M. (Meg) Mccarthy
Lead Independent Director
Lead Independent Director
95.38K
+14.75%
Ms. Jody L. Bilney
Ms. Jody L. Bilney
Independent Director
Independent Director
63.77K
+32.07%
Dr. Hyong (Ken) Kim, M.D.
Dr. Hyong (Ken) Kim, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. John E. Kao
Mr. John E. Kao
Chief Executive Officer, Director
Chief Executive Officer, Director
5.35M
+68.63%
Mr. Joseph S. Konowiecki
Mr. Joseph S. Konowiecki
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
862.50K
+1.44%
Mr. Robert L. Scavo
Mr. Robert L. Scavo
Chief Information Officer
Chief Information Officer
702.95K
+60.92%
Mr. Christopher J. Joyce, J.D.
Mr. Christopher J. Joyce, J.D.
Chief Legal and Administrative Officer
Chief Legal and Administrative Officer
415.02K
-5.68%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
327.44K
+3.89%
Dr. Jacqueline B. Kosecoff
Dr. Jacqueline B. Kosecoff
Independent Director
Independent Director
250.87K
+5.14%
收入明细
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
United States
2.70B
0.00%
业务
地区
暂无数据
股东统计
更新时间: 2月23日 周日
更新时间: 2月23日 周日
持股股东
股东类型
持股股东
股东统计
占比
General Atlantic LLC
30.87%
Fidelity Management & Research Company LLC
8.28%
The Vanguard Group, Inc.
4.96%
T. Rowe Price Investment Management, Inc.
4.38%
BlackRock Institutional Trust Company, N.A.
3.91%
Other
47.61%
持股股东
股东统计
占比
General Atlantic LLC
30.87%
Fidelity Management & Research Company LLC
8.28%
The Vanguard Group, Inc.
4.96%
T. Rowe Price Investment Management, Inc.
4.38%
BlackRock Institutional Trust Company, N.A.
3.91%
Other
47.61%
股东类型
股东统计
占比
Private Equity
30.87%
Investment Advisor
24.88%
Investment Advisor/Hedge Fund
18.98%
Hedge Fund
13.57%
Individual Investor
6.17%
Research Firm
1.17%
Pension Fund
0.18%
Bank and Trust
0.15%
Sovereign Wealth Fund
0.15%
Other
3.88%
机构持股
更新时间: 2月22日 周六
更新时间: 2月22日 周六
报告期
机构数
持股数
持股占比
持股变动
2025Q1
354
190.62M
96.46%
+2.56M
2024Q4
366
185.10M
96.49%
-4.29M
2024Q3
361
175.79M
91.75%
-18.07M
2024Q2
350
177.50M
92.81%
-16.13M
2024Q1
345
173.65M
90.84%
-16.06M
2023Q4
340
174.44M
92.27%
-18.71M
2023Q3
340
173.65M
91.94%
-19.56M
2023Q2
331
172.91M
91.73%
-9.35M
2023Q1
320
174.26M
93.05%
-8.71M
2022Q4
312
177.19M
94.61%
+2.71M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
General Atlantic LLC
61.03M
31.81%
+37.42K
+0.06%
Mar 13, 2025
Fidelity Management & Research Company LLC
16.37M
8.53%
-535.68K
-3.17%
Dec 31, 2024
The Vanguard Group, Inc.
9.80M
5.11%
+166.84K
+1.73%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
8.65M
4.51%
+3.06M
+54.74%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
7.72M
4.03%
+600.44K
+8.43%
Dec 31, 2024
Wellington Management Company, LLP
7.44M
3.88%
+3.26M
+77.92%
Dec 31, 2024
Deerfield Management Company, L.P.
7.30M
3.81%
-3.55M
-32.71%
Dec 31, 2024
Kao (John E)
5.35M
2.79%
+2.18M
+68.63%
Mar 27, 2025
Hood River Capital Management LLC
4.95M
2.58%
+1.41M
+39.61%
Dec 31, 2024
Durable Capital Partners LP
4.59M
2.39%
-890.72K
-16.26%
Dec 31, 2024
查看更多
持股ETF
更新时间: 3 小时前
更新时间: 3 小时前
机构名称
占比
Innovator IBD 50 Fund ETF
3.35%
SPDR S&P Health Care Services ETF
2.36%
Counterpoint Quantitative Equity ETF
2.21%
Simplify Health Care ETF
1.73%
First Trust Small Cap Growth AlphaDEX Fund
0.86%
Federated Hermes MDT Small Cap Core ETF
0.56%
First Trust Small Cap Core Alphadex Fund
0.55%
Even Herd Long Short ETF
0.55%
Langar Global HealthTech ETF
0.32%
iShares U.S. Healthcare Providers ETF
0.3%
查看更多
Innovator IBD 50 Fund ETF
占比3.35%
SPDR S&P Health Care Services ETF
占比2.36%
Counterpoint Quantitative Equity ETF
占比2.21%
Simplify Health Care ETF
占比1.73%
First Trust Small Cap Growth AlphaDEX Fund
占比0.86%
Federated Hermes MDT Small Cap Core ETF
占比0.56%
First Trust Small Cap Core Alphadex Fund
占比0.55%
Even Herd Long Short ETF
占比0.55%
Langar Global HealthTech ETF
占比0.32%
iShares U.S. Healthcare Providers ETF
占比0.3%
分红派息
近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有